TOSATO, Sarah
 Distribuzione geografica
Continente #
EU - Europa 6.630
NA - Nord America 6.014
AS - Asia 4.480
SA - Sud America 826
AF - Africa 132
OC - Oceania 29
Continente sconosciuto - Info sul continente non disponibili 5
Totale 18.116
Nazione #
US - Stati Uniti d'America 5.887
RU - Federazione Russa 2.801
SG - Singapore 1.806
CN - Cina 1.411
GB - Regno Unito 1.134
BR - Brasile 682
IT - Italia 598
HK - Hong Kong 462
FR - Francia 429
DE - Germania 394
VN - Vietnam 343
FI - Finlandia 326
IE - Irlanda 310
SE - Svezia 307
KR - Corea 118
AR - Argentina 60
CA - Canada 59
ID - Indonesia 59
UA - Ucraina 56
IN - India 47
AT - Austria 46
NL - Olanda 45
MX - Messico 39
TR - Turchia 35
PL - Polonia 34
ES - Italia 33
ZA - Sudafrica 33
BD - Bangladesh 30
BE - Belgio 30
AU - Australia 28
EC - Ecuador 26
JP - Giappone 26
BJ - Benin 20
IQ - Iraq 19
TG - Togo 19
NP - Nepal 13
RO - Romania 13
CO - Colombia 12
GR - Grecia 12
VE - Venezuela 12
KE - Kenya 11
PY - Paraguay 11
UZ - Uzbekistan 11
EG - Egitto 10
LT - Lituania 10
CZ - Repubblica Ceca 9
JO - Giordania 9
MA - Marocco 9
PE - Perù 9
AZ - Azerbaigian 8
IL - Israele 8
IR - Iran 8
PK - Pakistan 8
TW - Taiwan 8
TN - Tunisia 7
AE - Emirati Arabi Uniti 6
CH - Svizzera 6
HN - Honduras 5
NO - Norvegia 5
SA - Arabia Saudita 5
SN - Senegal 5
UY - Uruguay 5
AL - Albania 4
BG - Bulgaria 4
BO - Bolivia 4
CL - Cile 4
KW - Kuwait 4
NI - Nicaragua 4
PA - Panama 4
PH - Filippine 4
PR - Porto Rico 4
PS - Palestinian Territory 4
AO - Angola 3
BA - Bosnia-Erzegovina 3
DK - Danimarca 3
EE - Estonia 3
GE - Georgia 3
GH - Ghana 3
JM - Giamaica 3
KG - Kirghizistan 3
LB - Libano 3
LV - Lettonia 3
OM - Oman 3
RS - Serbia 3
AM - Armenia 2
BH - Bahrain 2
CG - Congo 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
EU - Europa 2
GT - Guatemala 2
KH - Cambogia 2
KZ - Kazakistan 2
LK - Sri Lanka 2
SC - Seychelles 2
SI - Slovenia 2
SY - Repubblica araba siriana 2
A1 - Anonimo 1
BF - Burkina Faso 1
Totale 18.093
Città #
Southend 918
Moscow 910
Singapore 783
Chandler 747
Dallas 632
Ashburn 492
Woodbridge 466
Hong Kong 461
Jacksonville 434
Ann Arbor 342
Beijing 310
Dublin 306
Verona 264
Houston 239
New York 180
The Dalles 167
Lawrence 137
Princeton 135
Wilmington 133
Ho Chi Minh City 105
Los Angeles 101
Jinan 86
Lappeenranta 82
Hanoi 79
Nanjing 77
Helsinki 72
Nuremberg 69
Redondo Beach 69
Columbus 58
São Paulo 58
Buffalo 57
Sindelfingen 57
Milan 55
Tianjin 53
Shenyang 50
Hebei 48
Jakarta 41
Munich 37
Santa Clara 37
Seattle 36
Falls Church 34
London 34
Zhengzhou 34
Guangzhou 32
Brussels 29
Changsha 28
Dong Ket 28
Frankfurt am Main 28
Nanchang 28
San Francisco 28
Taizhou 27
Vienna 27
Warsaw 27
Jiaxing 26
Boardman 25
Haikou 24
Hangzhou 23
Redmond 23
Amsterdam 22
Ningbo 22
Brooklyn 21
Montreal 21
Cotonou 20
Council Bluffs 20
Phoenix 20
Poplar 20
Rio de Janeiro 20
Atlanta 19
Lomé 19
Tokyo 19
Washington 19
Denver 17
Mexico City 17
Chennai 16
Rome 16
Fuzhou 15
Norwalk 15
Taiyuan 15
Boston 14
Brasília 14
Redwood City 14
Stockholm 14
Turku 14
Ankara 13
Lanzhou 13
Orem 13
Belo Horizonte 12
Curitiba 12
Johannesburg 12
Kent 12
Baghdad 11
Guayaquil 11
Kathmandu 11
Santo André 11
Sydney 10
Tashkent 10
Timisoara 10
Toronto 10
Chicago 9
Durban 9
Totale 10.520
Nome #
A multi-element psychosocial intervention for early psychosis (GET UP PIANO TRIAL) conducted in a catchment area of 10 million inhabitants: study protocol for a pragmatic cluster randomized controlled trial. 281
The biological correlates of childhood trauma in first episode psychosis 224
Is Neuregulin 1 Involved in Determining Cerebral Volumes in Schizophrenia? Preliminary Results Showing a Decrease in Superior Temporal Gyrus Volume 210
CHILDHOOD TRAUMATIC EXPERIENCES AND MENTAL HEALTH: INVESTIGATING BIOLOGICAL, PSYCHOLOGICAL AND SOCIAL CORRELATES 202
Gender differences in clinical features and quality of life of patients with axial spondyloarthritis and psoriatic arthritis 201
Classification of first-episode psychosis in a large cohort of patients using support vector machine and multiple kernel learning techniques 196
Psychosis Incident Cohort Outcome Study (PICOS). A multisite study of clinical, social and biological characteristics, patterns of care and predictors of outcome in first-episode psychosis. Background, methodology and overview of the patient sample 195
A survey on experienced and anticipated discrimination in first-episode psychotic patients: findings from the PICOS project 187
The impact of cannabis use on age of onset and clinical characteristics in first-episode psychotic patients. Data from the Psychosis Incident Cohort Outcome Study (PICOS) 183
Is there any relationship among parental styles, premorbid functioning and clinical presentation in a cohort of first episode psychotic patients? Results from the PICOS project 182
Experienced and anticipated discrimination in first-episode psychotic patients: pattern, severity and relationship with clinical and social factors: findings from the picos projetc 181
Pathway of care in first episode psychotic patients treated in community based mental health services. Findings from the PICOS-Veneto project 178
Development of a registry for monitoring psychotropic drug prescriptions: Aims, methods and implications for ordinary practice and research 176
Association study of dysbindin gene with clinical and outcome measures in a representative cohort of Italian schizophrenic patients 175
First-contact incidence of psychosis in north-eastern Italy: influence of age, gender, immigration and socioeconomic deprivation 173
Association between the Neuregulin 1 Gene and schizophrenia: A systematic review 172
Association between COMT gene and aggression in chronic schizophrenia 169
Gender differences in the onset of psychosis. Preliminary findings from th PICOS project 169
Classification of first-episode psychosis: a multi-modal multi-feature approach integrating structural and diffusion imaging 168
A large replication study and meta-analysis in European samples provides further support for association of AHI1 markers with schizophrenia 166
All SNPs are not created equal: genome-wide association studies reveal a consistent pattern of enrichment among functionally annotated SNPs. 165
Association between BDNF, NRG1 and DTNBP1 and outcome measures in an italian cohort of patients with schizophrenia 164
Association of dysbindin with outcome measures in a cohort of italian schizophrenic patients. 163
No Association Between NRG1 and ErbB4 Genes and Psychopathological Symptoms of Schizophrenia 163
Effect of COMT genotype on aggressive behaviour in a community cohort of schizophrenic patients 161
Neurological soft signs and prepulse inhibition of the startle reflex in psychosis: A pilot study 159
The influence of gender on clinical and social characteristics of patients at psychosis onset: A Report from the Psychosis Incident Cohort Outcome Study (PICOS) 158
The role of experienced and anticipated discrimination in the lives of people with first-episode psychosis. 157
Influence of childhood trauma on diagnosis and substance use in first-episode psychosis 155
Family burden, emotional distress and service satisfaction in first episode psychosis. Data from the GET UP trial 155
Association between the COMT gene and neurological abnormalities and poorer executive function in psychosis 154
Neurological soft signs and prepulse inhibition of the startle reflex in psychosis: a pilot study 151
Positive symptoms in first-episode psychosis patients experiencing low maternal care and stressful life events: a pilot study to explore the role of the COMT gene 150
Influence of perceived organizational factors on job burnout: an italian survey of menatl health staff. Findings from the PICOS project 146
A systematized review of atypical antipsychotics in pregnant women: balancing between risks of untreated illness and risks of drug-related adverse effects 144
The role of COMT gene in vulnerability to affective symptoms in schizophrenia 143
Time course of illicit drug use among FEP patients: data from the POCOS-Veneto study after one yesr of follow-up 143
Dimensional structure of first episode psychosis 143
Depression is associated with increased disease activity and higher disability in a large Italian cohort of patients with rheumatoid arthritis 143
Feasibility and Effectiveness of a Multi-Element Psychosocial Intervention for First-Episode Psychosis: Results From the Cluster-Randomized Controlled GET UP PIANO Trial in a Catchment Area of 10 Million Inhabitants 142
Two year outcomes and predictors in first-episode psychotic patients treated in community mental health services. Findings from the PICOS study 141
The use of dynamic susceptibility contrast (DSC) MRI to automatically classify patients with first episode psychosis 140
Coping strategies, emotional distress and perceived disease severity in a cohort of patients with rheumatoid arthritis: a mediation analysis 139
SUbstance misuse in first episode psychotic patients: different clinical presentation and risk factors? Data from the PICOS-VENETO project 139
Association of AADAC Deletion and Gilles de la Tourette Syndrome in a Large European Cohort 139
Treated incidence of psychotic disorders in the multinational EU-GEI study 138
Schizophrenia risk from complex variation of complement component 4 137
Substance misuse in first episode psychotic patients: sociodemographic, premorbid and clinical correlates. data from the PICOS-Veneto study 137
At-risk variant in TCF7L2 for type II diabetes increases risk of schizophrenia. 137
Association between genetic variation in a region on chromosome 11 and schizophrenia in large samples from Europe. 136
BDNF and COMT intaraction in determining clinical presentation of first-episode psychosis: data from the PICOS-Veneto study 136
Age at first birth in women is genetically associated with increased risk of schizophrenia 136
Identifying Gene-Environment Interactions in Schizophrenia: Contemporary Challenges for Integrated, Large-scale Investigations 134
Implementing evidence-based treatments in routine mental health services: strategies, obstacles, new developments to better target care provided 134
Can the role of genetic factors in schizophrenia be enlightened by studies of candidate gene mutant mice behaviour? 133
The contribution of epidemiology to defining the most appropriate approach to genetic research on schizophrenia 133
Transcriptomic analyses and leukocyte telomere length measurement in subjects exposed to severe recent stressful life events 133
The psychopathology of schizophrenia and the presence of neurological soft signs: a review 132
Genetic pleiotropy between multiple sclerosis and schizophrenia but not bipolar disorder: differential involvement of immune-related gene loci 130
Association study of nonsynonymous single nucleotide polymorphisms in schizophrenia. 126
Genome-wide association analysis identifies 13 new risk loci for schizophrenia 125
A Genome-wide Association Analysis of a Broad Psychosis Phenotype Identifies Three Loci for Further Investigation 124
Predictors and moderators of treatment outcome in patients receiving multi-element psychosocial intervention for early psychosis: results from the GET UP pragmatic cluster randomised controlled trial 124
COMT, neuropsychological function and brain structure in schizophrenia: a systematic review and neurobiological interpretation 123
Modeling Linkage Disequilibrium Increases Accuracy of Polygenic Risk Scores 122
Common variants conferring risk of schizophrenia 122
Large recurrent microdeletions associated with schizophrenia 120
Biological insights from 108 schizophrenia-associated genetic loci 119
Epigenetics and gene expression profile in First-Episode Psychosis: the role of Childhood Trauma 119
Childhood and adulthood severe stressful experiences and biomarkers related to glucose metabolism: a possible association? 118
Childhood adversity, symptoms, and cortisol in first episode psychosis: a cross-sectional, secondary, observational analysis of a subsample of FEP patients 116
Contrasting genetic architectures of schizophrenia and other complex diseases using fast variance-components analysis 112
Pathways to care, DUP, and types of interventions over 5 years following psychosis onset: findings from a naturalistic study conducted in routine generalist mental health services 112
Cannabis and cognition: connecting the dots towards the understanding of the relationship 112
Gender and 5-years course of psychosis patients: focus on clinical and social variables 109
Disruption of the neurexin 1 gene is associated with schizophrenia 107
Predictors of 9-month hospitalization in patients with first-episode affective and non-affective psychosis. Results from the GET UP pragmatic cluster randomized controlled trial 107
Clinical and psychological characteristics associated with negative beliefs and concerns about treatment necessity in rheumatic diseases 106
Copy number variations of chromosome 16p13.1 region associated with schizophrenia 106
The impact of cannabis use on age of onset in first-episode psychotic patients 105
Comparison and potential determinants of health-related quality of life among rheumatoid arthritis, psoriatic arthritis, and spondyloarthritis: A cross-sectional study 105
Bridging the gap between education and appropriate use of benzodiazepines in psychiatric clinical practice 103
Genome-wide association study reveals greater polygenic loading for schizophrenia in cases with a family history of illness 103
The EUropean Network of National Schizophrenia Networks Studying Gene-Environment Interactions (EU-GEI): incidence and first-episode case-control programme 103
A Genome-Wide Association Study of First-Episode Psychosis: A Genetic Exploration in an Italian Cohort 102
Childhood trauma and glucose metabolism in patients with first-episode psychosis 101
Prevalence of non-psychotic disorders in ultra-high risk individuals and transition to psychosis: A systematic review 101
Common variants at VRK2 and TCF4 conferring risk of schizophrenia. 100
Psychiatric disorders 99
Replication Study and Meta-Analysis in European Samples Supports Association of the 3p21.1 Locus with Bipolar Disorder 97
The impact of gender and childhood abuse on age of psychosis onset, psychopathology and needs for care in psychosis patients 97
The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study 97
A polygenic resilience score moderates the genetic risk for schizophrenia 97
Depression as a possible determinant of fatigue in patients with axial spondyloarthritis 94
The role of genetics in the vulnerability to psychosis and in predicting clinical outcome. Data from the Psychosis Incident Cohort Outcome Study (PICOS) 94
Variability in Working Memory Performance Explained by Epistasis vs Polygenic Scores in theZNF804APathway 91
Jumping to conclusions, general intelligence, and psychosis liability: findings from the multi-centre EU-GEI case-control study 91
The independent effects of psychosocial stressors on subclinical psychosis: findings from the multinational EU-GEI study 91
Genetic schizophrenia risk variants jointly modulate total brain and white matter volume. 89
Convergent lines of evidence support CAMKK2 as a schizophrenia susceptibility gene 89
Totale 13.809
Categoria #
all - tutte 68.231
article - articoli 56.879
book - libri 0
conference - conferenze 8.644
curatela - curatele 0
other - altro 886
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.822
Totale 136.462


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021416 0 0 0 0 0 70 22 57 95 30 75 67
2021/2022876 64 122 38 81 36 41 15 85 43 34 80 237
2022/20232.134 160 206 217 367 169 497 23 139 227 28 61 40
2023/20241.255 48 86 81 158 132 251 57 113 19 99 150 61
2024/20253.556 173 218 144 626 138 163 207 167 563 272 248 637
2025/20266.437 730 579 710 1.714 2.401 303 0 0 0 0 0 0
Totale 18.354